Drugs / RUTI®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04903184 | Jan → Nov 2021 | COVID-19 | RUTI Immunotherapeutics S.L. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RUTI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04903184 ↗ |
| Modality | Vaccine | “RUTI® vaccine” NCT04903184 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT04903184 ↗ |